Heron Therapeutics, Inc. (HRTX)

NCM – Real Time Price. Currency in USD

0.35

+0.03 (9.13%)

Market open: Aug 12, 2026, 12:01 PM EDT

0.32

-0.00 (-0.99%)

Previous after-hours: Aug 11, 2026, 7:58 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

155M

144M

127M

108M

Cost of goods sold

-41M

-39M

-65M

-55M

Gross Profit

114M

106M

62M

53M

Operating expenses (excl. COGS)

-116M

-117M

-173M

-222M

Operating Income

-3M

-12M

-111M

-169M

Non-operating income, total

-18M

-2M

56K

-13M

Pretax income

-20M

-14M

-111M

-182M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-20M

-14M

-111M

-182M

Discontinued operations

Net income

-20M

-14M

-111M

-182M

Dilution adjustment

Preferred dividends

Heron Therapeutics, Inc. (HRTX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Heron Therapeutics, Inc. (HRTX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Heron Therapeutics, Inc. (HRTX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Heron Therapeutics, Inc. (HRTX)

Income Statement (Annual)

Income Statement (Annual)